Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Ferrer

Showing results (271-280 of 319) with videos related to

Pageof 32
Sort By:
Scientific Reports|April 21, 2023
Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational studyLuis Felipe Reyes, Alejandro Rodriguez, Yuli V Fuentes, et al.
Acta Anaesthesiologica Scandinavica|July 6, 2019
Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis planTine Sylvest Meyhoff, Peter Buhl Hjortrup, Morten Hylander Møller, et al.
Archivos De Bronconeumologia|October 11, 2021
[Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection]César Cinesi Gómez, Óscar Peñuelas Rodríguez, Manel Luján Torné, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2025
Status of Sepsis Care in European Hospitals: Results from an International Cross-Sectional SurveyChristian S Scheer, Evangelos J Giamarellos-Bourboulis, Ricard Ferrer, et al.
Medicina Intensiva|April 22, 2020
[Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection]César Cinesi Gómez, Óscar Peñuelas Rodríguez, Manel Luján Torné, et al.
Critical Care (London, England)|November 15, 2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Bruno François, Marc Bourgeois, et al.
Critical Care (London, England)|February 16, 2021
Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in SpainAlejandro Rodríguez, Manuel Ruiz-Botella, Ignacio Martín-Loeches, et al.
Archivos De Bronconeumologia|September 4, 2023
Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched AnalysisCatia Cilloniz, Anna Motos, Joan Canseco, et al.
The Lancet. Respiratory Medicine|May 9, 2021
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entityMarcin F Osuchowski, Martin S Winkler, Tomasz Skirecki, et al.
Journal of Internal Medicine|October 6, 2021
Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patientsMaría Martin-Vicente, Raquel Almansa, Isidoro Martínez, et al.
Pageof 32

Showing results (271-280 of 319) with videos related to

Sort By:
Pageof 32
Scientific Reports|April 21, 2023
Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational studyLuis Felipe Reyes, Alejandro Rodriguez, Yuli V Fuentes, et al.
Acta Anaesthesiologica Scandinavica|July 6, 2019
Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis planTine Sylvest Meyhoff, Peter Buhl Hjortrup, Morten Hylander Møller, et al.
Archivos De Bronconeumologia|October 11, 2021
[Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection]César Cinesi Gómez, Óscar Peñuelas Rodríguez, Manel Luján Torné, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2025
Status of Sepsis Care in European Hospitals: Results from an International Cross-Sectional SurveyChristian S Scheer, Evangelos J Giamarellos-Bourboulis, Ricard Ferrer, et al.
Medicina Intensiva|April 22, 2020
[Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection]César Cinesi Gómez, Óscar Peñuelas Rodríguez, Manel Luján Torné, et al.
Critical Care (London, England)|November 15, 2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Bruno François, Marc Bourgeois, et al.
Critical Care (London, England)|February 16, 2021
Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in SpainAlejandro Rodríguez, Manuel Ruiz-Botella, Ignacio Martín-Loeches, et al.
Archivos De Bronconeumologia|September 4, 2023
Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched AnalysisCatia Cilloniz, Anna Motos, Joan Canseco, et al.
The Lancet. Respiratory Medicine|May 9, 2021
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entityMarcin F Osuchowski, Martin S Winkler, Tomasz Skirecki, et al.
Journal of Internal Medicine|October 6, 2021
Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patientsMaría Martin-Vicente, Raquel Almansa, Isidoro Martínez, et al.
Pageof 32